Allyl-isothiocyanate causes mitotic block, loss of cell adhesion and disrupted cytoskeletal structure in HT29 cells

Tracy K Smith1, Elizabeth K Lund, Mary L Parker

  • 1Institute of Food Research, Norwich Research Park, Colney, Norwich NR4 7UA, UK.

Carcinogenesis
|March 23, 2004
PubMed

Insights

Allyl-isothiocyanate (AITC), found in Brassica vegetables, inhibits colorectal cancer cell proliferation by disrupting alpha-tubulin and causing a mitotic block. This mechanism offers potential for new cancer chemotherapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Nutritional Science

Background:

  • Epidemiological studies suggest Brassica vegetables offer protection against colorectal cancer.
  • Glucosinolates, abundant in Brassicas, yield breakdown products with antiproliferative properties against cancer cells.

Purpose of the Study:

  • To investigate the effects of allyl-isothiocyanate (AITC), a key sinigrin breakdown product, on colorectal cancer cell proliferation and death.
  • To elucidate the mechanism by which AITC impacts cancer cell cycle and survival.

Main Methods:

  • HT-29 colorectal cancer cells were exposed to AITC for 24 hours.
  • Cell proliferation, cell-cycle arrest, apoptosis, and alpha-tubulin disruption were assessed using microscopy and flow cytometry.

Main Results:

  • AITC treatment caused cancer cells to round up and detach.
  • Cells exhibited a mitotic block at 24 hours post-treatment.
  • Morphological and Annexin V staining revealed no apoptosis, but significant alpha-tubulin disruption was observed.

Conclusions:

  • AITC inhibits colorectal cancer cell proliferation through a mechanism involving mitotic arrest and alpha-tubulin disruption.
  • This action is similar to established chemotherapeutic agents, suggesting potential therapeutic applications.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...